These findings, coupled to the evidence that shallow deletions in CBX3 gene are significantly associated to low copy gain in RAC1 gene (Supplementary Fig. 10F), argue for the possibility that this specific combination in CNAs between CBX3 and RAC1 loci may be indeed positively selected during cancer development to confer an evolutionary advantage to transformed cells. The gene discussed is CBX3; the disease is cancer.